SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant discussion following reports that Nvidia has paused evaluating its 18A chipmaking process, a crucial element of Intel's revitalized foundry strategy. However, much of the community is highly skeptical, calling the news old or manipulative, and arguing that 18A was primarily for internal use while future external foundry deals, potentially including Nvidia, are centered on the more advanced 14A node. Many investors express frustration over perceived short-term price suppression, yet maintain long-term confidence in Intel's competitive positioning.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

OMER is trending on high anticipation for an imminent FDA approval decision for its drug Narsoplimab, targeting a deadly disease with no approved treatments. The community is buzzing with speculation around a potential "Christmas miracle" approval, fueled by the company's recent strategic partnership with Novo Nordisk and strong clinical data, anticipating a significant short squeeze and a re-rating of the stock's value despite past regulatory hurdles.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending with high excitement following the successful orbital deployment of its BlueBird 6 satellite, a pivotal step towards delivering 5G connectivity directly to standard smartphones globally. The community views this milestone as a validation of ASTS's direct-to-device vision and a significant catalyst for future growth, generating widespread bullish sentiment and discussions about its long-term potential in the space sector.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is experiencing significant positive momentum, driven by its upcoming inclusion in the S&P MidCap 400 index, effective early next year. The community views this as a major catalyst for structural demand, anticipating increased institutional buying, enhanced liquidity, and greater visibility for the Agentic AI and automation leader.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust is surging to new all-time highs, driven by intensifying industrial demand from rapidly expanding sectors like AI data centers, EVs, and solar, alongside significant global supply concerns. The rally is further fueled by China's impending export restrictions on silver, with market participants eagerly discussing a potential 'silver squeeze' and a fundamental re-evaluation of its value, though some anticipate a near-term correction after its rapid ascent.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is a major talking point as Sanofi announced its acquisition for $15.50 per share, valuing the company at $2.2 billion and representing a substantial premium. This move integrates Dynavax's marketed adult Hepatitis B vaccine, its shingles candidate, and a recently licensed oral COVID-19 vaccine program into Sanofi's global immunization portfolio. While many long-term shareholders are relieved to see a resolution, a significant portion of the community feels the acquisition price undervalues the company's assets and growth prospects.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amidst intensified speculation for a major partnership or buyout, catalyzed by a recent acquisition in the biotech sector and heightened discussions around its undervalued protein-based vaccine platform and combination influenza/COVID candidate. Shareholders are openly frustrated with management's perceived inaction and lack of communication, echoing an activist investor's push for a strategic review to unlock value from Novavax's differentiated non-mRNA technology, especially as concerns about mRNA vaccine safety grow. This confluence of factors, coupled with high short interest, positions the company for potentially significant market movement should a transformative deal be announced.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following FDA approval of AQVESME (mitapivat) for thalassemia-associated anemia, marking the first oral medicine for this patient population. This significant regulatory milestone is driving conversations about its commercial opportunity, though community sentiment remains polarized due to prior delays in regulatory decisions and mixed clinical trial results for other indications. Discussions are ongoing regarding the drug's market potential and the broader implications for the company's trajectory amidst persistent concerns about past management decisions and overall stock performance.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is experiencing extreme volatility as a recent low-float IPO, captivating traders with its explosive price discovery. The community is debating its potential for a short squeeze against concerns about long-term fundamentals and market manipulation, positioning it as a high-risk, high-reward meme stock within the broader aerospace sector.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is heavily trending amid widespread speculation of an imminent buyout, fueled by recent significant insider purchases and strong financial fundamentals including growing Lupkynis sales and a robust cash position. The community is actively discussing the potential Phase 2 indications for AUR200, while many shareholders voice frustration over perceived management opacity and repeatedly call for a change in leadership to unlock further value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ZJK Industrial (NASDAQ:ZJK) Shares Down 8.5% - What's Next?

ZJK Industrial (NASDAQ:ZJK) Stock Price Down 8.5% - Here's Why...

ZJK Industrial (ZJK) said Thursday it plans to scale up production to support Nvidia’s (NVDA) B40 initiative, a specialized AI chip project targeting the Chinese market.<a href="https://stocktwits.com/symbol/NVDA">Nvidia’s stock</a> edged 0.5% higher at the market open on Thursday, while&nbsp;<a href="https://stocktwits.com/symbol/ZJK">ZJK’s stock</a> jumped more than 11%.&nbsp;The B40 is based on Nvidia’s Blackwell architecture and is designed for the mid-to-high-end segment. ZJK said mass production could begin as early as June 2025, positioning the company to benefit from rising demand in the region."The B40 project presents several compelling market advantages. It complements Nvidia's RTX Pro 6000 workstation graphics cards currently being sold worldwide," ZJK CEO Ning Ding said in a statement. "According to supply chain forecasts, B40 chip shipments are expected to exceed one million units by the end of 2025."Ding emphasized the opportunity to expand alongside Nvidia’s push into China’s AI market. “As a supplier to Nvidia, we see tremendous growth potential in this project, given the market size and surging demand in the AI sector,” he said. “We expect this initiative to contribute significant year-over-year revenue growth.”ZJK added that it aims to leverage the B40 ramp-up to enhance its own business operations. “With our continued dedication to innovation and manufacturing excellence, we are confident in our ability to capture new opportunities and drive long-term growth, business upgrades, and strategic expansion,” Ding said.The B40 project has drawn attention as Nvidia works to maintain its footprint in China while complying with U.S. export controls.&nbsp;While the company’s most advanced chips face restrictions, the B40 represents a pathway for Nvidia to serve one of the world’s largest AI markets through a customized and compliant solution.Nvidia’s stock has gained 4.5% year-to-date, while ZJK’s shares have fallen nearly 45% in the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-back-in-the-drivers-seat-hikes-price-target-to-165-on-ai-demand/chkDSwoRbDU">Nvidia ‘Back In The Driver’s Seat,’ Says Daiwa, Hikes Price Target To $165 On AI Demand&nbsp;</a>

A general view of Nvidia headquarters is seen in Shanghai, China, on May 19, 2025, as Nvidia plans further investment for the Shanghai research center. (Photo by Ying Tang/NurPhoto via Getty Images)

ZJK Ramps Up Production To Back Nvidia’s China-Focused B40 Chip

ZJK Industrial CEO Ning Ding stated that the company anticipates B40 chip shipments to surpass one million units by the end of 2025.

Equity

Shares of precision fasteners manufacturer ZJK Industrial Co. more than doubled on Tuesday after the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2024/12/03/2990553/0/en/ZJK-Industrial-Expands-Collaboration-with-NVIDIA-into-Liquid-Cooling-Systems.html">disclosed</a> that it received a request to produce samples for one of NVIDIA’s upcoming liquid cooling manifold projects.In response to the request, the company has assembled a specialized team of engineers and technical support specialists to focus exclusively on NVIDIA’s liquid cooling systems.“This team ensures ZJK’s standards of fast, high-quality production while aligning with NVIDIA’s evolving needs,” it said.CEO Ning Ding said the meeting at NVIDIA’s headquarters was encouraging for several reasons.“Not only did NVIDIA’s team praise ZJK for our efforts on the existing collaboration, but it also resulted in a new request for liquid cooling manifold components. The expansion of our cooperation into liquid cooling systems provides our company the opportunity to demonstrate the breadth of our capabilities, the strength of our R&amp;D teams and the quality and versatility of our engineering,” he said.Ding added that the firm hopes to remain one of NVIDIA’s preferred suppliers of precision parts manufacturing and will do everything possible to ensure the continued success of the collaborative effort.<a href="https://stocktwits.com/symbol/ZJK">Shares of ZJK Industrial</a> soared nearly 137% on Tuesday following the announcement.A poll on Stocktwits indicated maximum followers of the ticker expect the collaboration with NVIDIA to pay-off.<figure class="image"><img style="aspect-ratio:1838/1018;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_03_at_2_19_46_PM_f2601005c1.png" alt="Screenshot 2024-12-03 at 2.19.46 PM.png" width="1838" height="1018"></figure>Meanwhile, most retail followers of ZJK Industrial shares on Stocktwits expressed optimism about the firm.<stembedurl>https://stocktwits.com/KennyN/message/594910103</stembedurl><stembedurl>https://stocktwits.com/Greywolf11/message/594909070</stembedurl><stembedurl>https://stocktwits.com/Kerz/message/594904605</stembedurl>Meanwhile, shares of the company have gained over 200% since its listing at the end of September.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/fedex-stock-dips-after-bernstein-downgrade/cJ9NC0eRhV">FedEx Stock Dips After Bernstein Downgrade, But JPMorgan Price Target Hike Lifts Retail Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A poll on Stocktwits indicated maximum followers of the ticker expect the collaboration with NVIDIA to pay-off. | Representative Image Source: Pixabay

ZJK Industrial Stock More Than Doubles After NVIDIA Collaboration: Retail Chatter Indicates Extreme Optimism

CEO Ning Ding said the meeting at NVIDIA’s headquarters was encouraging for several reasons.

ZJK Industrial Co., Ltd. engages in the manufacturing and sale of precision fasteners, structural parts and other precision metal parts products. Its products include standard screws, nuts, bolts, turning parts, stamping parts and computer numerical control machining parts. The company was founded in 2011 and is headquartered in Shenzhen, China.

ZJK
ZJK Industrial Co Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZJK News

ZJKZJK Industrial Co Ltd.